FrontierView recently held a webinar to help multinational clients understand the implications of COVID-19 on Asia Pacific (APAC) markets. Major markets around the globe will fall into contractionary territory this year, with significant implications for APAC’s healthcare outlook.

The webinar focuses on how Asia’s healthcare landscape will fare in the face of the novel coronavirus’ rapid spread and its aftereffects. The discussion covers on how pharmaceutical and medical device companies are confronting demand planning, digital engagement models, supply chain/localization pressures and strategic planning for a post-COVID19 landscape.

Watch the recording to understand how governments will react and revamp their healthcare reform agendas in the face of a more challenging fiscal environment for the long term across developed and emerging Asia. We also explore how China, Japan, South Korea, India and ASEAN markets will fare in the “new normal” of a post-COVID19 world.

APAC’s Healthcare Outlook from FrontierView on Vimeo.

For all of our latest updates and impacts for global business, visit our COVID-19 Resource Hub, a centralized location with all of the latest insights from our expert analysts that your business needs to navigate continued uncertainty surrounding COVID-19. You can also subscribe to The Lens, a weekly newsletter published by FrontierView’s Global Economics and Scenarios team, to receive the latest insights in your inbox every Thursday.